Apoptosis

Tante visite, una diagnosi “by proxy”: ALPS, la sindrome linfoproliferativa autoimmune

L. Sirianni, M. Mancuso

2013/1

Autoimmune lymphoproliferative syndrome or ALPS is a genetic disease associated with anomalous apoptosis in lymphocytes, lymphoproliferation and autoimmune manifestations. Generally, it is possible to observe severe lymphadenopathy, hepatosplenomegal...

ß-talassemia (Parte prima)

G. Bartolozzi

2006/1

Ancora biopsia? Forse no!

S. De Virgilis

2005/7 — pag. 437-455

Recently, serum of celiac patients affected by autoimmune hepatitis revealed autoantibodies directed against actin filaments (AAA). The preliminary results regarding AAA showed a strong correlation between AAA antibody titre and the severity of int...

FANS nella carcinogenesi del colon-retto

G. Bartolozzi

2004/3

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS). Efficacia della ciclofosfamide

E. Barth, M. Rabusin G.A. Zanazzo, P. Tamaro

2001/8

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS): efficacia della ciclofosfamide

E. Barth, M. Rabusin, GA. Zanazzo, P. Tamaro

2001/8 — pag. 548-548

Report of a very severe case of thrombocytopenia with lymphoproliferative autoimmune syndrome (hereditary ALPS) resistant to classical treatments, both in high doses or bolus, with prompt and durable response to cyclophosfamide....

Il sistema immune (Parte quinta)

G. Bartolozzi

2001/2

Il sistema immuneGlossario

G. Bartolozzi

2000/10

Inibizione dell'apoptosi da parte degli anticorpi monoclonali umani anti-transglutaminasili

A. Tommasini, M. Soban, I. Berti, C. Trevisiol, E. Panfili, D. Santon, V. Baldas, E. Fragonas

2000/6

Inibizione dell’apoptosi da parte degli anticorpi monoclonali umani anti-transglutaminasi

A. Tommasini, M. Soban, I. Berti, C. Trevisiol, E. Panfili, D. Santon, Lenhardt, V. Baldas, E. Fragonas

2000/6 — pag. 391-393

The celiac disease is characterized by the production of tTG (antitransglutaminase) antibodies. These antibodies could only be a marker of the disease, or, which is more likely, could be involved in the pathogenesis of intestinal lesions (inhibiti...

Nuovi usi per vecchi farmaci nelle malattie autoimmuni

L. Lepore e coll.

1999/6 — pag. 368-370

AUTOIMMUNITÀ NEL BAMBINOLa tolleranza immunitaria: un difficile equilibrio

L.D. Notarangelo

1999/6 — pag. 357-370

L’apoptosi nella fisiologia e nella patologia umana

T. Not, E. Buratti, I. Berti, C. Trevisiol, E. Neri, A. Tommasini

1998/4 — pag. 251-254